The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development.

Published

Journal Article (Review)

Atherosclerotic disease is recognized as a chronic inflammatory disorder with intermittent and widely variable phases of cellular proliferation and heightened thrombotic activity. The multi-tiered links between inflammation, atherogenesis and thrombogenesis provide a unique opportunity for research and development of pharmaceuticals which target one or more critical pathobiologic steps (Fig. 1). The purpose of the following review on heparin compounds is to comprehensively examine the multi-cellular, pleuripotential effects of a commonly used anticoagulant drug in the context of normal and disease-altered vascular responses and illustrate possible constructs for avenues of subsequent investigation in the field of atherothrombosis. The overview is divided into five integrated parts; antiinflammatory properties of the normal vessel wall, the relationship between glycosaminoglycans and inflammation, heparin-mediated effects on cellular inflammatory responses, association between molecular weight and antiinflammatory capabilities, and oral heparin compounds for achieving prolonged cell-based inhibition.

Full Text

Duke Authors

Cited Authors

  • Elsayed, E; Becker, RC

Published Date

  • February 2003

Published In

Volume / Issue

  • 15 / 1

Start / End Page

  • 11 - 18

PubMed ID

  • 14574071

Pubmed Central ID

  • 14574071

International Standard Serial Number (ISSN)

  • 0929-5305

Digital Object Identifier (DOI)

  • 10.1023/a:1026184100030

Language

  • eng

Conference Location

  • Netherlands